Ricardo Chinchilla-Monge

Dr. Ricardo Chinchilla-Monge

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2020 in Anticancer Research
Verified
Journal Article
Closed access
PDF file
AEAllan Ramos Esquivel
Allan Ramos Esquivel
Ricardo Chinchilla-MongeRicardo Chinchilla-Monge
Ricardo Chinchilla-Monge
MVMarta Valle
Marta Valle
Background/Aim: Enzymatic variants involved in fluoropyrimidine metabolism have been associated with adverse events (AEs). We assessed the association between C677T (rs1801133) and A1298 (rs1801131) methylenetetrahydrofolate reductase (MTHFR) polymorphisms and AEs in patients with first-line fluoropyrimidine-based chemotherapy. Patients and Methods: Fifty patients with metastatic colorectal cancer were prospectively followed-up during the first 4 cycles of fluoropyrimidine-based treatment to assess AEs. Germline DNA was analyzed to determine the C677T and A1298C MTHFR polymorphisms. The associations between MTHFR polymorphisms and toxicity were examined. Results: Individuals carrying at least one mutant allele of the MTHFR C677T polymorphism had increased risk to experience anemia (OR=1.69, 95% CI=1.13-2.53, p=0.005), neutropenia (OR=2.27, 95% CI=1.47-3.42, p<0.001) thrombocytopenia (OR=1.91, 95% CI=1.30-2.70, p<0.001), neuropathy (OR=1.77, 95% CI=1.16-2.70, p=0.02), diarrhea (OR=1.69, 95% CI=1.13-2.53, p=0.005), and hand-foot syndrome (OR=1.56, 95% CI=1.08-2.27, p=0.013), compared to patients carrying the wild type alleles. The presence of the mutant allele C of the MTHFR A1298C polymorphism was associated with increased risk of anemia (OR=2.75, 95% CI=1.01-7.48, p=0.02) and thrombocytopenia (OR=3.14, 95% CI=1.01-9.78, p=0.03); however, the prevalence of this allele in the sample was quite low (20%). Conclusion: MTHFR C677T and A1298C polymorphisms predicted toxicity in a subset of Mestizo patients with colorectal adenocarcinoma.

9 June 2021 in Pharmacogenetics and Genomics
Verified
Journal Article
Closed access
AEAllan Ramos Esquivel
Allan Ramos Esquivel
Ricardo Chinchilla-MongeRicardo Chinchilla-Monge
Ricardo Chinchilla-Monge
JAJad Abbas
Jad Abbas
MVMarta Valle
Marta Valle
Objective: To assess the association between C677T and A1298C methylenetetrahydrofolate reductase (MTHFR) single-nucleotide polymorphisms (SNPs) and response to first-line fluoropyrimidine-based chemotherapy for metastatic colorectal adenocarcinoma. Methods: A total of 68 patients were prospectively followed up in San Juan de Dios Hospital (San José, Costa Rica) from January 2019 to November 2020. Patients received first-line therapy with capecitabine or 5-fluorouracil in combination with oxaliplatin or irinotecan. Germline and somatic DNA was extracted from blood samples and paraffin-embedded tissue, respectively. Overall response rate (partial response + complete response) was assessed according to RECIST 1.1 criteria. Cox regression models were performed to identify the effect of MTHFR C677T and A1298C SNPs on progression-free survival (PFS) and overall survival (OS) (NCT registration number: 03852290). Results: Patients harboring one or both T alleles of the MTHFR C677T SNP had better overall response than homozygous wild-type individuals [odds ratio (OR): 3.21; 95% confidence interval (CI), 1.05–9.81; P = 0.03]. No association was found between the MTHFR A1298C genotypes and overall response (OR: 0.75; 95% CI, 0.26–2.20; P = 0.60). Patients with the MTHFR 677 TT and CT genotypes had longer PFS than CC individuals (hazard ratio: 0.53; 95% CI, 0.28–0.98; P = 0.045), even after adjustment for confounders (hazard ratio: 0.50; 95% CI, 0.25–0.98; P = 0.04). We found no association between the MTHFR A1298C SNP and PFS (hazard ratio: 1.35; 95% CI, 0.72–2.55; P = 0.34). None of the SNPs was associated with OS. Conclusion: Patients carrying at least one mutant allele of the MTHFR C677T SNP had a better overall response and longer PFS than wild-type homozygous patients.

4 September 2025 in Cells
Verified
Journal Article
Open access
PDF file
DEDiana Marcela Bravo Estupiñan
Diana Marcela Bravo Estupiñan
CGCarsten Geiß
Carsten Geiß
Jorge L. Arias-AriasJorge L. Arias-Arias
Jorge L. Arias-Arias
MMMariela Montaño-Samaniego
Mariela Montaño-Samaniego
Ricardo Chinchilla-MongeRicardo Chinchilla-Monge
Ricardo Chinchilla-Monge
RMRodrigo Mora
Rodrigo Mora
Background: Genomic instability, a hallmark of cancer, leads to copy number variations disrupting gene dosage balance and contributing to tumor progression. One of the most affected oncogenes is MYC, whose overexpression is tightly regulated to avoid cytotoxicity. In aneuploid cancer cells, gene dosage compensation mechanisms involving microRNAs (miRNAs) from the miR-17/92 cluster contribute in regulating MYC expression. Targeting this miRNA-mediated compensation system represents a promising therapeutic strategy leading to an uncontrolled and lethal MYC overexpression. Results: Synthetic miRNA sponges targeting miR-17, miR-19a, and miR-20a, key regulators of MYC dosage compensation, were designed and validated. Breast cancer cells (MCF7) with stable exogenous MYC overexpression were used to assess the impact of sponge constructs on MYC regulation. Quantitative RT-PCR revealed a significant reduction in miRNA expression and a corresponding increase in endogenous MYC levels upon sponge treatment. Functional assays in multiple colorectal cancer cell lines with varying MYC copy numbers demonstrated a time-dependent increase in cell death following sponge transfection. Cytotoxic effects increased with MYC copy number, confirming a correlation between gene dosage sensitivity and therapeutic response. Conclusions: Our findings demonstrate that miRNA sponges targeting the miR-17/92 cluster can effectively disrupt MYC dosage compensation, leading to selective cytotoxicity in MYC-amplified cancer cells.

1 April 2023 in Acta Medica Costarricense
Verified
Journal Article
Open access
PDF file
MGMariann González-Salazar
Mariann González-Salazar
Ricardo Chinchilla-MongeRicardo Chinchilla-Monge
Ricardo Chinchilla-Monge
ISIleana Holst Schumacher
Ileana Holst Schumacher
MRMax Ruiz-Corella
Max Ruiz-Corella
MCMinor Calderón-Jiménez
Minor Calderón-Jiménez
MSMauro Barrantes- Santamaría
Mauro Barrantes- Santamaría
Objetivo: Caracterizar un grupo de mujeres universitarias costarricenses con síndrome de ovario poliquístico mediante una evaluación clínica y bioquímica. Métodos: Estudio observacional-descriptivo en que participaron 160 mujeres costarricenses con edades comprendidas entre los 17 y 28 años con el fin de identificar posibles asociaciones al síndrome de ovario poliquístico. Se estudiaron algunas de sus características físicas y parámetros clínicos, como sobrepeso, acné, hirsutismo, abortos espontáneos y trastornos menstruales, junto con parámetros bioquímicos, tales como glucosa, perfil lipídico, insulina, testosterona total y TSH, entre otros. Los datos fueron analizados aplicando estadística descriptiva. La prueba t-Student se utilizó para comparar los promedios de las variables con distribución normal, mientras que la prueba de Mann-Whitney se realizó para variables no paramétricas. Un valor de p < 0,05 se consideró como significativo. Los coeficientes de Spearman se utilizaron para determinar los niveles de correlación entre las diferentes variables del estudio. Resultados: Las mujeres con síndrome de ovario poliquístico presentaron valores significativamente más altos en relación con las mujeres sin el síndrome en las variables de peso (p = 0,003), el índice de masa corporal (p < 0,001), así como de la concentración sanguínea de testosterona total (p < 0,001), LDLcolesterol (p = 0,020), triglicéridos (p < 0,001) y el índice de Castelli (p < 0,001). La concentración de HDL-colesterol (p < 0,001) fue más alta en las mujeres sin el síndrome. Además, se observó una proporción más alta de mujeres con el síndrome que presentaban resistencia a la insulina (p = 0,007), la relación LH/ FSH > 2,8 (p = 0,009), hirsutismo (p = 0,001), trastornos menstruales (p=0,029) y obesidad (p=0,014) en comparación con las mujeres sin el síndrome. Conclusiones: El hiperandrogenismo, la resistencia a la insulina, la concentración de lípidos alterada e índices de Castelli elevados son los parámetros bioquímicos más prevalentes en la muestra de mujeres costarricenses con síndrome de ovario poliquístico. La ejecución de proyectos con perfiles bioquímicos más amplios junto con pruebas de ultrasonido son los nuevos retos para futuras investigaciones del síndrome de ovario poliquístico en Costa Rica.

15 November 2022
Verified
Conference Paper
Closed access
AJAbbas-Chakhtoura Jad
Abbas-Chakhtoura Jad
Ricardo Chinchilla-MongeRicardo Chinchilla-Monge
Ricardo Chinchilla-Monge
MRMora-Rodriguez Rodrigo
Mora-Rodriguez Rodrigo
Lung carcinoid tumors are malignant neuroendocrine neoplasms that account for less than 2% of all lung malignancies and include two histological types: typical and atypical carcinoid tumors. Typical carcinoid tumors do not include areas of necrosis and show less than 2 mitotic figures within 10 high grade fields. On the molecular level, carcinoid tumors present alterations in gene MEN1 as well as a high expression of genes ASCL1 and EIF1AX. We report a systems biology approach using BioNetUCR and Copasi in addition to Cytoscape to identify mi-RNA regulators of the most important altered genes in typical pulmonary carcinoid tumors. The final adjusted and reduced interaction network of our genes of interest included: 3 genes 12 transcription factors and 7 mi-RNAs, leading to a total of 22 nodes and 53 edges. Analysis with Copasi showed that MIR24-2 regulates the expression of MEN1 and MIR129-1 regulates the expression of AIF1AX. Those mi-RNAs could be potential targets for molecular therapy in patients with typical carcinoid tumor of lung.

24 May 2023 in Revista Alergia México
Verified
Journal Article
Open access
PDF file
MCMariela Carvajal-Elizondo
Mariela Carvajal-Elizondo
OMOlga Patricia Monge-Ortega
Olga Patricia Monge-Ortega
Ricardo Chinchilla-MongeRicardo Chinchilla-Monge
Ricardo Chinchilla-Monge
SQSteve Quiros
Steve Quiros
Antecedentes: El síndrome de Stevens-Johnson es una reacción medicamentosa severa. Las sulfamidas se han asociado con reacciones medicamentosas, complicaciones, secuelas, incluso la muerte. Reporte de caso: Paciente femenina de 40 años, con antecedentes médicos de endometriosis y colitis ulcerativa crónica inflamatoria de reciente diagnóstico. Fue atendida en el servicio de Alergología del Hospital San Juan de Dios de la Caja Costarricense del Seguro Social, y luego de 20 días de tratamiento con sulfasalazina tuvo una reacción medicamentosa severa en la piel, compatible con síndrome de Stevens-Johnson. La prueba de transformación linfocitaria resultó positiva, con lo que se confirmó la sulfasalazina como el agente causal. Conclusiones: La prueba de transformación linfocitaria es un método útil que puede confirmar el agente causal y prevenir complicaciones importantes a futuro. Palabras clave: Síndrome de Stevens-Johnson; reacción medicamentosa grave; sulfonamidas; sulfasalazina; prueba de transformación linfocitaria.